Integral Derivatives’s Celgene Corp CELG Stock Holding History

Integral Derivatives’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1.27M	Buy	+14,233	New	+$1.37M	0.03%	187
2017 Q4	–	Sell	-9,326	Closed	-$1.05M	–	1383
2017 Q3	$1.36M	Sell	9,326 -6,064	-39%	-$826K	0.02%	404
2017 Q2	$2M	Sell	15,390 -8,780	-36%	-$1.08M	0.04%	306
2017 Q1	$3.01M	Buy	+24,170	New	+$2.89M	0.05%	224
2016 Q4	–	Sell	-13,325	Closed	-$1.48M	–	1357
2016 Q3	$1.39M	Buy	+13,325	New	+$1.44M	0.03%	355
2016 Q2	–	Sell	-3,436	Closed	-$355K	–	1187
2016 Q1	$344K	Buy	+3,436	New	+$354K	0.01%	606
2015 Q2	–	Sell	-11,399	Closed	-$1.3M	–	1394
2015 Q1	$1.31M	Buy	11,399 +366	+3%	+$43.7K	0.03%	428
2014 Q4	$1.23M	Sell	11,033 -26,163	-70%	-$2.76M	0.02%	598
2014 Q3	$3.52M	Sell	37,196 -7,692	-17%	-$694K	0.06%	275
2014 Q2	$3.85M	Buy	44,888 +33,748	+303%	+$2.57M	0.07%	232
2014 Q1	$778K	Buy	+11,140	New	+$882K	0.01%	739

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Integral Derivatives's CELG Position: Q1 2018 in Review

Integral Derivatives opened a new position in Celgene Corp (CELG) in Q1 2018: 14,233 shares worth $1.27M. The stake represents 0.03% of the portfolio and ranks #187 among its holdings. This is a return to the name: Integral Derivatives previously reported a position in CELG as recently as Q3 2017.

Integral Derivatives first reported a position in CELG in Q1 2014 and has held it in 11 quarters since. The position peaked at $3.85M in Q2 2014. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Integral Derivatives held 14,233 shares of Celgene Corp worth $1.27M as of Q1 2018.
Celgene Corp was a new Integral Derivatives position in Q1 2018.
Celgene Corp made up 0.03% of Integral Derivatives's portfolio in Q1 2018, its #187 holding.
Integral Derivatives first reported a position in Celgene Corp in Q1 2014 and has held it in 11 quarters since.
Integral Derivatives's Celgene Corp position peaked at $3.85M in Q2 2014.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.